Cathepsin K preferentially solubilizes matured bone matrix

Calcified Tissue International

Volumn 91, Issue 1, 2012, Pages 32-39

  Borel, Olivier ^a   Gineyts, Evelyne ^a   Bertholon, Cindy ^a   Garnero, Patrick ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Parc Marcel Boiteux ^*  (France)

Author keywords

Bone matrix solubilization; Cathepsin K; Type I collagen posttranslational modification

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOXY TERMINAL TELOPEPTIDE; CATHEPSIN K; COLLAGEN; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; HYDROXYPROLINE; PENTOSIDINE; PYRIDINOLINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE AGE; BONE MATRIX; BONE MATURATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICAL BONE; COW; CROSS LINKING; DEGRADATION KINETICS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME RELEASE; FETUS; IN VITRO STUDY; ISOMER; ISOMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

AMINO ACIDS; ANIMALS; ARGININE; BONE DENSITY; BONE MATRIX; CATHEPSIN K; CATTLE; COLLAGEN; COLLAGEN TYPE I; HUMANS; ISOMERISM; LYSINE; PEPTIDES;

EID: 84863471584     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9604-7     Document Type: Article

References (46)

1. Eyre DR, Oguchi H (1980) The hydroxypyridinium cross-links of skeletal collagens: their measurement, properties and a proposed pathway of formation. Biochem Biophys Res Commun 92:403-410 (Pubitemid 10098580)
2. Eyre DR (1980) Collagen: molecular diversity in the body's protein scaffold. Science 207:1315-1322
3. Robins SP, Bailey AJ (1972) Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products. Biochem Biophys Res Commun 48:76-84
4. Sell DR, Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264:21597-21602 (Pubitemid 20028722)
5. DeGroot J (2004) The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 4:301-305
6. Geiger T, Clarke S (1987) Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem 262:785-794 (Pubitemid 17005254)
7. Cloos PA, Fledelius C (2000) Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 345(Pt 3):473-480 (Pubitemid 30099075)
8. Gineyts E, Cloos PA, Borel O, Grimaud L, Delmas PD, Garnero P (2000) Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover. Biochem J 345(Pt 3):481-485 (Pubitemid 30099076)
9. Fledelius C, Johnsen AH, Cloos PA, Bonde M, Qvist P (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region. J Biol Chem 272:9755-9763 (Pubitemid 27171639)
10. Wang X, Shen X, Li X, Agrawal CM (2002) Age-related changes in the collagen network and toughness of bone. Bone 31:1-7 (Pubitemid 34754417)
11. Nyman JS, Roy A, Tyler JH, Acuna RL, Gayle HJ, Wang X (2007) Age-related factors affecting the postyield energy dissipation of human cortical bone. J Orthop Res 25:646-655 (Pubitemid 46730517)
12. Zioupos P, Currey JD (1998) Changes in the stiffness, strength, and toughness of human cortical bone with age. Bone 22:57-66 (Pubitemid 28033654)
13. Knott L, Bailey AJ (1998) Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22:181-187 (Pubitemid 28127472)
14. Viguet-Carrin S, Follet H, Gineyts E, Roux JP, Munoz F, Chapurlat R, Delmas PD, Bouxsein ML (2010) Association between collagen cross-links and trabecular microarchitecture properties of human vertebral bone. Bone 46:342-347
15. Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD (2002) Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Miner Res 17:826-833 (Pubitemid 34441899)
16. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28:195-201 (Pubitemid 32140975)
17. Viguet-Carrin S, Farlay D, Bala Y, Munoz F, Bouxsein ML, Delmas PD (2008) An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties. Bone 42:139-149 (Pubitemid 350302015)
18. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, Garnero P (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282:5691-5703 (Pubitemid 47093757)
19. Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD (2006) Extracellular posttranslational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38:300-309 (Pubitemid 43255423)
20. Henriksen K, Leeming DJ, Byrjalsen I, Nielsen RH, Sorensen MG, Dziegiel MH, Martin TJ, Christiansen C, Qvist P, Karsdal MA (2007) Osteoclasts prefer aged bone. Osteoporos Int 18: 751-759 (Pubitemid 46684778)
21. Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238
22. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse JM (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347-32352 (Pubitemid 29177183)
23. Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ, Gelb BD (1999) Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 14:1902-1908 (Pubitemid 29521785)
24. Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504-513 (Pubitemid 36890583)
25. Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP (1998) Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331(Pt 3):727-732 (Pubitemid 28211893)
26. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA (1996) Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271:12517-12524 (Pubitemid 26160924)
27. 2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271:2126-2132
28. Silver IA, Murrills RJ, Etherington DJ (1988) Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175:266-276
29. Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Bromme D (2002) Collagenase activity of cathepsin Kdepends on complex formation with chondroitin sulfate. J Biol Chem 277:28669-28676
30. Li Z, Yasuda Y, Li W, Bogyo M, Katz N, Gordon RE, Fields GB, Bromme D (2004) Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J Biol Chem 279:5470-5479 (Pubitemid 38220571)
31. Viguet-Carrin S, Gineyts E, Bertholon C, Delmas PD (2009) Simple and sensitive method for quantification of fluorescent enzymatic mature and senescent cross-links of collagen in bone hydrolysate using single-column high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 877:1-7
32. Cloos PA, Lyubimova N, Solberg H, Qvist P, Christiansen C, Byrjalsen I, Christgau S (2004) An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone. Clin Lab 50:279-289 (Pubitemid 38877727)
33. Bank RA, Krikken M, Beekman B, Stoop R, Maroudas A, Lafeber FP, te Koppele JM (1997) A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 16:233-243 (Pubitemid 27503810)
34. Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaisse JM (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859-867 (Pubitemid 37294969)
35. Bauer D, Garnero P, Harrson SL, Cauley J, Eastell R, Orwoll E (2010) Type I collagen isomerization (alpha/beta CTX ratio) and risk of clinical vertebral fracture in men: a prospective study. ASBMR 2010 Annual Meeting. J Bone Miner Res 25 (Suppl 1):S8
36. Li Z, Hou WS, Bromme D (2000) Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39:529-536 (Pubitemid 30077626)
37. Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195-214
38. Eyre DR, Paz MA, Gallop PM (1984) Cross-linking in collagen and elastin. Annu Rev Biochem 53:717-748 (Pubitemid 14059149)
39. Bailey AJ, Paul RG, Knott L (1998) Mechanisms of maturation and ageing of collagen. Mech Ageing Dev 106:1-56 (Pubitemid 28559274)
40. Atley LM, Mort JS, Lalumiere M, Eyre DR (2000) Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope. Bone 26:241-247 (Pubitemid 30101647)
41. Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M, Risteli J (2000) Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 26:367-373 (Pubitemid 30136127)
42. Cao L, Goodin R, Wood D, Moscarello MA, Whitaker JN (1999) Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry 38:6157-6163
43. Pritzker LB, Joshi S, Gowan JJ, Harauz G, Moscarello MA (2000) Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39:5374-5381 (Pubitemid 30257077)
44. Eriksen EF (2010) Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11:219-227
45. Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD (1997) Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. J Bone Miner Res 12:1407-1415 (Pubitemid 27375383)
46. Leeming DJ, Delling G, Koizumi M, Henriksen K, Karsdal MA, Li B, Qvist P, Tanko LB, Byrjalsen I (2006) Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion. Cancer Epidemiol Biomarkers Prev 15:1392-1395 (Pubitemid 44125298)